Daniel A. Achinko
Howard University,USA.
Biography
Daniel Achinko completed his PhD in Biochemistry from the University of Egerton, Njoro, Kenya in May 2013, under a grant at the International Center for Insect Physiology and Ecology (icipe) while working on the transgenesis of malaria vectors as a control technique against malaria. He took special interest in bioinformatics of therapy design leading him to a Postdoc at the National Institutes of Health in the USA. Through a joint collaboration with PepVax/ImMAGEbio, a biotechnology company currently working on a Triple Negative Breast Cancer (TNBC) related drug, he became vice president of the scientific department. The current bioinformatics analysis performed by their group in driving the right immune response against antigens has been included in the National Genome Center Program for Innovation to solve the disease burden. He has published several articles on cancer antigenic epitopes driving proper immune response